Vaccines | Tenderlake

Vaccines

Contract Value:
EUR 616K - 616K
Notice Type:
Contract Notice
Published Date:
14 April 2023
Closing Date:
18 May 2023
Location(s):
EE EESTI (EE Estonia/EESTI)
Description:
Buying vaccines

Purchase of vaccines for 24 months according to real need.

West Tallinn Central Hospital 24 months

East Tallinn Central Hospital from 06.06.2024 until the end of the contract

SA Jõgeva Hospital 24 months

cholera causative agent, inactivated, total cell susp and effervescent granules

cholera causative agent, inactivated, total cell susp and effervescent granules

influenza virus, live , weakened nasal spray, suspension

influenza virus, live , weakened nasal spray, suspension

hepatitis B virus, purified antigen suspension for injection

hepatitis B virus, purified antigen suspension for injection

hepatitis A total virus, inactivated suspension for injection

hepatitis A total virus, inactivated suspension for injection

hepatitis A total virus, inactivated suspension for injection

hepatitis A total virus, inactivated suspension for injection

hepatitis A total virus, inactivated + hepatitis B virus, purified antigen suspension for injection in a syringe

hepatitis A total virus, inactivated + hepatitis B virus, purified antigen suspension for injection in a syringe

measles agent, live, attenuated +rubella maker, live attenuated +mumps virus, live, attenuated suspension powder and solvent

measles agent, live, attenuated +rubella maker, live attenuated +mumps virus, live, attenuated suspension powder and solvent

total polio virus, trivalent, inactivated suspension for injection

total polio virus, trivalent, inactivated suspension for injection

total rabies virus, powder and solvent for inactivated suspension for injection

total rabies virus, powder and solvent for inactivated suspension for injection

chickenpox virus, live, attenuated powder and solvent for solution for injection

chickenpox virus, live, attenuated powder and solvent for solution for injection

shingles virus, live, attenuated suspension powder and solvent

shingles virus, live, attenuated suspension powder and solvent

Meningococcus, tetravalent conjugated purified polysaccharide antigen INJ solution powder and solvent

Meningococcus, tetravalent conjugated purified polysaccharide antigen INJ solution powder and solvent

Shingles virus, purified antigen suspension powder for injection and suspension for injection

Shingles virus, purified antigen suspension powder for injection and suspension for injection

the causative agent of yellow fever, live, powder and solvent of the attenuated suspension for injection

the causative agent of yellow fever, live, powder and solvent of the attenuated suspension for injection

Human papillomavirus (strains 6, 11, 16, 18, 31, 33, 45, 52, 58) suspension for injection in a syringe

Human papillomavirus (strains 6, 11, 16, 18, 31, 33, 45, 52, 58) suspension for injection in a syringe

diphtheria toxoid+pertussis agent, purified antigen +tetanus toxoid+total polio virus, trivalent, inactivated suspension for injection

diphtheria toxoid+pertussis agent, purified antigen +tetanus toxoid+total polio virus, trivalent, inactivated suspension for injection

J07CA09 süstesuspensioon (süstlis)

diphtheria toxoid+tetanus toxoid+pertussis agent, purified antigen +poliomyelitis total virus, trivalent, inactivated +haemophilus influenzae B, conjugated, purified antigen + hepatitis B virus purified antigen suspension for injection (syringe)

meningococcus B, a multicomponent vaccine (must also be suitable for infants) suspension for injection

meningococcus B, a multicomponent vaccine (must also be suitable for infants) suspension for injection

Pneumococcus, purified polysaccharide antigen solution for injection

Pneumococcus, purified polysaccharide antigen solution for injection

Pneumococcus, purified polysaccharide antigen, conjugated ,15-valent suspension for injection in a syringe

Pneumococcus, purified polysaccharide antigen, conjugated ,15-valent suspension for injection in a syringe

Pneumococcus, purified polysaccharide antigen, conjugated ,20-valent suspension for injection

Pneumococcus, purified polysaccharide antigen, conjugated ,20-valent suspension for injection

causative agent of typhoid fever, purified polysaccharide antigen solution for injection in a syringe

causative agent of typhoid fever, purified polysaccharide antigen solution for injection in a syringe

Diphtheria-tetanus-pertussis suspension for injection in a syringe

Diphtheria-tetanus-pertussis suspension for injection in a syringe

total virus of tick-borne encephalitis, inactivated suspension for injection in a syringe

total virus of tick-borne encephalitis, inactivated suspension for injection in a syringe

Download full details as .pdf
The Buyer:
Aktsiaselts Lääne-Tallinna Keskhaigla
CPV Code(s):
33651600 - Vaccines